List of Tables
Table 1. Global Cancer Ablation Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cancer Ablation Devices Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cancer Ablation Devices Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cancer Ablation Devices Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cancer Ablation Devices Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cancer Ablation Devices Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cancer Ablation Devices Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cancer Ablation Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cancer Ablation Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cancer Ablation Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cancer Ablation Devices, Product Type & Application
Table 12. Global Key Manufacturers of Cancer Ablation Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cancer Ablation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Ablation Devices as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Ablation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cancer Ablation Devices Sales by Region (2020-2025) & (K Units)
Table 18. Global Cancer Ablation Devices Sales Market Share by Region (2020-2025)
Table 19. Global Cancer Ablation Devices Sales by Region (2026-2031) & (K Units)
Table 20. Global Cancer Ablation Devices Sales Market Share by Region (2026-2031)
Table 21. Global Cancer Ablation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cancer Ablation Devices Revenue Market Share by Region (2020-2025)
Table 23. Global Cancer Ablation Devices Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cancer Ablation Devices Revenue Market Share by Region (2026-2031)
Table 25. North America Cancer Ablation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cancer Ablation Devices Sales by Country (2020-2025) & (K Units)
Table 27. North America Cancer Ablation Devices Sales by Country (2026-2031) & (K Units)
Table 28. North America Cancer Ablation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cancer Ablation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cancer Ablation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cancer Ablation Devices Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cancer Ablation Devices Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cancer Ablation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cancer Ablation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cancer Ablation Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cancer Ablation Devices Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cancer Ablation Devices Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cancer Ablation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cancer Ablation Devices Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Ablation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cancer Ablation Devices Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cancer Ablation Devices Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cancer Ablation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Ablation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cancer Ablation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cancer Ablation Devices Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cancer Ablation Devices Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cancer Ablation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cancer Ablation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cancer Ablation Devices Sales (K Units) by Type (2020-2025)
Table 51. Global Cancer Ablation Devices Sales (K Units) by Type (2026-2031)
Table 52. Global Cancer Ablation Devices Sales Market Share by Type (2020-2025)
Table 53. Global Cancer Ablation Devices Sales Market Share by Type (2026-2031)
Table 54. Global Cancer Ablation Devices Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cancer Ablation Devices Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cancer Ablation Devices Revenue Market Share by Type (2020-2025)
Table 57. Global Cancer Ablation Devices Revenue Market Share by Type (2026-2031)
Table 58. Global Cancer Ablation Devices Price (US$/Unit) by Type (2020-2025)
Table 59. Global Cancer Ablation Devices Price (US$/Unit) by Type (2026-2031)
Table 60. Global Cancer Ablation Devices Sales (K Units) by Application (2020-2025)
Table 61. Global Cancer Ablation Devices Sales (K Units) by Application (2026-2031)
Table 62. Global Cancer Ablation Devices Sales Market Share by Application (2020-2025)
Table 63. Global Cancer Ablation Devices Sales Market Share by Application (2026-2031)
Table 64. Global Cancer Ablation Devices Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cancer Ablation Devices Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cancer Ablation Devices Revenue Market Share by Application (2020-2025)
Table 67. Global Cancer Ablation Devices Revenue Market Share by Application (2026-2031)
Table 68. Global Cancer Ablation Devices Price (US$/Unit) by Application (2020-2025)
Table 69. Global Cancer Ablation Devices Price (US$/Unit) by Application (2026-2031)
Table 70. Alfresa Pharma Corp. Company Information
Table 71. Alfresa Pharma Corp. Description and Business Overview
Table 72. Alfresa Pharma Corp. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Alfresa Pharma Corp. Cancer Ablation Devices Product
Table 74. Alfresa Pharma Corp. Recent Developments/Updates
Table 75. AngioDynamics, Inc. Company Information
Table 76. AngioDynamics, Inc. Description and Business Overview
Table 77. AngioDynamics, Inc. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AngioDynamics, Inc. Cancer Ablation Devices Product
Table 79. AngioDynamics, Inc. Recent Developments/Updates
Table 80. BTG plc (Galil Medical Ltd./Perseon Medical) Company Information
Table 81. BTG plc (Galil Medical Ltd./Perseon Medical) Description and Business Overview
Table 82. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product
Table 84. BTG plc (Galil Medical Ltd./Perseon Medical) Recent Developments/Updates
Table 85. Biomedical S.r.l. Company Information
Table 86. Biomedical S.r.l. Description and Business Overview
Table 87. Biomedical S.r.l. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biomedical S.r.l. Cancer Ablation Devices Product
Table 89. Biomedical S.r.l. Recent Developments/Updates
Table 90. Boston Scientific Corporation Company Information
Table 91. Boston Scientific Corporation Description and Business Overview
Table 92. Boston Scientific Corporation Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Boston Scientific Corporation Cancer Ablation Devices Product
Table 94. Boston Scientific Corporation Recent Developments/Updates
Table 95. CSA Medical, Inc. Company Information
Table 96. CSA Medical, Inc. Description and Business Overview
Table 97. CSA Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. CSA Medical, Inc. Cancer Ablation Devices Product
Table 99. CSA Medical, Inc. Recent Developments/Updates
Table 100. Chongqing Haifu Medical Technology Co., Ltd Company Information
Table 101. Chongqing Haifu Medical Technology Co., Ltd Description and Business Overview
Table 102. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product
Table 104. Chongqing Haifu Medical Technology Co., Ltd Recent Developments/Updates
Table 105. ECO Medical Company Information
Table 106. ECO Medical Description and Business Overview
Table 107. ECO Medical Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. ECO Medical Cancer Ablation Devices Product
Table 109. ECO Medical Recent Developments/Updates
Table 110. EDAP TMS S.A. Company Information
Table 111. EDAP TMS S.A. Description and Business Overview
Table 112. EDAP TMS S.A. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. EDAP TMS S.A. Cancer Ablation Devices Product
Table 114. EDAP TMS S.A. Recent Developments/Updates
Table 115. HS Hospital Service S.p.A. Company Information
Table 116. HS Hospital Service S.p.A. Description and Business Overview
Table 117. HS Hospital Service S.p.A. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. HS Hospital Service S.p.A. Cancer Ablation Devices Product
Table 119. HS Hospital Service S.p.A. Recent Developments/Updates
Table 120. IceCure Medical, Inc. Company Information
Table 121. IceCure Medical, Inc. Description and Business Overview
Table 122. IceCure Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. IceCure Medical, Inc. Cancer Ablation Devices Product
Table 124. IceCure Medical, Inc. Recent Developments/Updates
Table 125. Johnson & Johnson (Ethicon, Inc.) Company Information
Table 126. Johnson & Johnson (Ethicon, Inc.) Description and Business Overview
Table 127. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product
Table 129. Johnson & Johnson (Ethicon, Inc.) Recent Developments/Updates
Table 130. Kang-Yu Medical Co., Ltd. Company Information
Table 131. Kang-Yu Medical Co., Ltd. Description and Business Overview
Table 132. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product
Table 134. Kang-Yu Medical Co., Ltd. Recent Developments/Updates
Table 135. MedLink Technologies LLC Company Information
Table 136. MedLink Technologies LLC Description and Business Overview
Table 137. MedLink Technologies LLC Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. MedLink Technologies LLC Cancer Ablation Devices Product
Table 139. MedLink Technologies LLC Recent Developments/Updates
Table 140. MedWaves, Inc. Company Information
Table 141. MedWaves, Inc. Description and Business Overview
Table 142. MedWaves, Inc. Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. MedWaves, Inc. Cancer Ablation Devices Product
Table 144. MedWaves, Inc. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Cancer Ablation Devices Distributors List
Table 148. Cancer Ablation Devices Customers List
Table 149. Cancer Ablation Devices Market Trends
Table 150. Cancer Ablation Devices Market Drivers
Table 151. Cancer Ablation Devices Market Challenges
Table 152. Cancer Ablation Devices Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cancer Ablation Devices
Figure 2. Global Cancer Ablation Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Ablation Devices Market Share by Type: 2024 & 2031
Figure 4. Cryoablation Product Picture
Figure 5. High-Intensity Focused Ultrasound (HIFU) Product Picture
Figure 6. Laser Interstitial Thermal Therapy (LiTT) Product Picture
Figure 7. Microwave Ablation (MWA) Product Picture
Figure 8. Radiofrequency Ablation (RFA) Product Picture
Figure 9. Irreversible Electroporation (Ire) Product Picture
Figure 10. Non-Thermal Ablation Product Picture
Figure 11. Global Cancer Ablation Devices Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Cancer Ablation Devices Market Share by Application: 2024 & 2031
Figure 13. Brain Cancer
Figure 14. Brown
Figure 15. Colorectal Cancer
Figure 16. Kidney Cancer
Figure 17. Liver Cancer
Figure 18. Lung Cancer
Figure 19. Pancreatic Cancer
Figure 20. Prostate Cancer
Figure 21. Global Cancer Ablation Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Cancer Ablation Devices Market Size (2020-2031) & (US$ Million)
Figure 23. Global Cancer Ablation Devices Sales (2020-2031) & (K Units)
Figure 24. Global Cancer Ablation Devices Average Price (US$/Unit) & (2020-2031)
Figure 25. Cancer Ablation Devices Report Years Considered
Figure 26. Cancer Ablation Devices Sales Share by Manufacturers in 2024
Figure 27. Global Cancer Ablation Devices Revenue Share by Manufacturers in 2024
Figure 28. Global 5 and 10 Largest Cancer Ablation Devices Players: Market Share by Revenue in Cancer Ablation Devices in 2024
Figure 29. Cancer Ablation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 30. Global Cancer Ablation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 31. North America Cancer Ablation Devices Sales Market Share by Country (2020-2031)
Figure 32. North America Cancer Ablation Devices Revenue Market Share by Country (2020-2031)
Figure 33. U.S. Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Canada Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Europe Cancer Ablation Devices Sales Market Share by Country (2020-2031)
Figure 36. Europe Cancer Ablation Devices Revenue Market Share by Country (2020-2031)
Figure 37. Germany Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. France Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. U.K. Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Italy Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Russia Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Asia Pacific Cancer Ablation Devices Sales Market Share by Region (2020-2031)
Figure 43. Asia Pacific Cancer Ablation Devices Revenue Market Share by Region (2020-2031)
Figure 44. China Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Japan Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. South Korea Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. India Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Australia Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Taiwan Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Indonesia Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Thailand Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Malaysia Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Philippines Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Latin America Cancer Ablation Devices Sales Market Share by Country (2020-2031)
Figure 55. Latin America Cancer Ablation Devices Revenue Market Share by Country (2020-2031)
Figure 56. Mexico Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Brazil Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Argentina Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Cancer Ablation Devices Sales Market Share by Country (2020-2031)
Figure 60. Middle East and Africa Cancer Ablation Devices Revenue Market Share by Country (2020-2031)
Figure 61. Turkey Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Saudi Arabia Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. UAE Cancer Ablation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. Global Sales Market Share of Cancer Ablation Devices by Type (2020-2031)
Figure 65. Global Revenue Market Share of Cancer Ablation Devices by Type (2020-2031)
Figure 66. Global Cancer Ablation Devices Price (US$/Unit) by Type (2020-2031)
Figure 67. Global Sales Market Share of Cancer Ablation Devices by Application (2020-2031)
Figure 68. Global Revenue Market Share of Cancer Ablation Devices by Application (2020-2031)
Figure 69. Global Cancer Ablation Devices Price (US$/Unit) by Application (2020-2031)
Figure 70. Cancer Ablation Devices Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
